Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Innovation Council · Running

PLAST_CELL A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy

Coordinator
Fundacio Centre De Regulacio Genomica, Spain
Runs
1 May 2022 to 31 October 2026
Status
Running
EU funding
€3.0m
Total cost
€3.0m
Partners
6 organisations in 4 countries
Type
European Innovation Council
Grant agreement
101046620

What the project is doing

In the project's own words, from its summary on CORDIS.

Metastasis is the major cause of death in cancer patients due to cancer cell dissemination to distant organs. Cell plasticity is a core characteristic of metastatic cells and confers cellular adaptation capabilities to variable mechano-chemical tissue microenvironments. However, to date, specific quantitative measures of cancer cell plasticity associated with tumour aggressiveness and therapy resistance have remained difficult to establish.

A major limitation is the availability of highthroughput multiplexed assays that can capture phenotypic heterogeneity and morphodynamic plasticity at the single cell level in standardized 3D culture conditions reflecting in vivo tissue microenvironments. The PLAST_CELL interdisciplinary consortium will pioneer the development of a microfluidics-based imaging platform to categorize and score cancer cell plasticity within diverse physiologically relevant 3D biomimetic culture conditions.

The platform will enable to perform single cell multi-scale morphometric and molecular live cell data collection (PLAST_DATA) with minimal sample size (<10k cells). Data will be generated based on single molecule-sensitivity marker detection and cellular/subcellular morphodynamic feature recognition via minimal-invasive long-term super-resolution microscopy and parallel morphodynamic imaging of cellular behaviour. Computational integration of PLAST_DATA using preclinical models and patient samples will enable to develop a quantitative classification of tumour cell plasticity and predictive scoring of cancer aggressiveness, metastasis and drug resistance (PLAST_SCORE).

The ability to assess cell plasticity based on cellular behaviours is beyond current clinical parameters and will strongly impact diagnosis, prognosis and treatments. The PLAST_CELL platform will be a technology breakthrough to establish new quantitative standards to evaluate cell plasticity and mechanisms of tumour malignancy for a new era of basic research and personalized medicine.

Topics

Who is involved

OrganisationCityCountryRole
Fundacio Centre De Regulacio GenomicaBarcelonaSpainCoordinator
Universitaet InnsbruckInnsbruckAustriaParticipant
European Molecular Biology LaboratoryHeidelbergGermanyParticipant
Fundacio Institut De Ciencies FotoniquesCastelldefelsSpainParticipant
Fundacio Institut Hospital Del Mar D Investigacions MediquesBarcelonaSpainParticipant
Cherry BiotechMontreuilFranceParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI